Usui I, Kawano H, Ito S, Hamada Y, Ishihara T, Maeda S
First Department of Biochemistry, Yamanashi Medical University, Tamaho-cho, Yamanashi 409-3898, Japan.
Amyloid. 2001 Jun;8(2):101-4. doi: 10.3109/13506120109007351.
Serum amyloid P component (SAP) is a common protein constituent of all types of amyloid deposits. Using SAP-deficient mice generated through gene targeting, we and others have shown that SAP significantly promotes amyloid deposition. It has been speculated that SAP protects amyloid fibrils from degradation by coating their exterior surface. To assess potential ways of treating individuals with amyloidosis, we examined the persistence of splenic AA amyloid fibrils in SAP-deficient and wild-type mice. No enhancement in the rate of regression of splenic AA amyloid was observed in the SAP-deficient mice relative to wild-type mice. These results present, for the first time, evidence that lack of SAP in AA amyloid deposits does not enhance regression of the deposits in vivo and suggest that dissociation of bound SAP from AA amyloid deposits would not significantly accelerate regression of the deposits in vivo.
血清淀粉样蛋白P成分(SAP)是所有类型淀粉样沉积物的常见蛋白质成分。通过基因靶向技术构建的SAP缺陷小鼠,我们和其他研究人员已表明,SAP显著促进淀粉样蛋白沉积。据推测,SAP通过覆盖淀粉样纤维的外表面来保护其不被降解。为了评估治疗淀粉样变性患者的潜在方法,我们检测了SAP缺陷小鼠和野生型小鼠脾脏中AA淀粉样纤维的持久性。与野生型小鼠相比,SAP缺陷小鼠脾脏中AA淀粉样蛋白的消退速率没有增强。这些结果首次表明,AA淀粉样沉积物中缺乏SAP不会增强其在体内的消退,并表明结合在AA淀粉样沉积物上的SAP解离不会显著加速其在体内的消退。